Биостатистика, фармакокинетика и клинические исследования.

Домашняя страница
- О сайте
Материалы
- Быстрые команды R Project
- Ссылки
Инструменты
- Рандомизационный список
Блог
Контакты
Профиль
- Войти
- Зарегистрироваться

Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
Главные ошибки при формировании базы данных в MS Excel
Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
Julia:ReplicateBE – release 0.2.0

Галерея

Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 16, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-08
Human medicines European public assessment report (EPAR): Obgemsa, vibegron, Date of authorisation: 27/06/2024, Revision: 2, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-08
Human medicines European public assessment report (EPAR): Holoclar, ex vivo expanded autologous human corneal epithelial cells containing stem cells, Date of authorisation: 17/02/2015, Revision: 13, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-08
Human medicines European public assessment report (EPAR): Erleada, apalutamide, Date of authorisation: 14/01/2019, Revision: 17, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-08
Biosimilars Research: Awards
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-07 By FDA
FDA Public Meeting: BsUFA III Regulatory Science Program Interim Public Meeting - 09/18/2025
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-07 By FDA
What's New Related to Drugs
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-07 By FDA
Drug Trials Snapshot: ROMVIMZA
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-07 By FDA
Endothelin Receptor Antagonist REMS Information
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-07 By FDA
CDER Manual of Policies & Procedures | MAPP
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-07 By FDA
Emergency Use Authorizations for Drugs and Non-Vaccine Biological Products
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-07 By FDA
Generic Drugs Program Monthly and Quarterly Activities Report
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-07 By FDA
Human medicines European public assessment report (EPAR): Latuda, lurasidone, Date of authorisation: 21/03/2014, Revision: 28, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-07
Human medicines European public assessment report (EPAR): Circadin, melatonin, Date of authorisation: 29/06/2007, Revision: 37, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-07
Check Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-07 By FDA

Предыдущие записи

Тема: Scaffold от Danny Cooper.